Can we take enhancement drugs? It depends
The goal of my paper is show that we should abandon the treatment/enhancement distinction in favour of a particularist approach when evaluating the ethics of non-clinical uses of psychiatric drugs because there is no principled way to draw the distinction between treatment and enhancement. To mee...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Final Year Project |
| Language: | English |
| Published: |
2018
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10356/73596 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Nanyang Technological University |
| Language: | English |
| Summary: | The goal of my paper is show that we should abandon the treatment/enhancement
distinction in favour of a particularist approach when evaluating the ethics of non-clinical uses
of psychiatric drugs because there is no principled way to draw the distinction between
treatment and enhancement. To meet my paper’s objective: I will first introduce the
significance of the treatment/enhancement distinction in influencing healthcare policies. In
section two, I give reasons for why I think that if there was an objective way to capture the idea
of normal functioning, the statistical approach would be the best candidate. Next, in section
three, I will argue that both Tyrer and Steinberg’s and Boorse’s statistical approaches are
inadequate in giving us a defensible conception of normal functioning. In light of this, I propose
in the fourth and final section, that we should consider the particularist approach over the
generalist approach. |
|---|